Methylphenylsulfide

Methylphenylsulfide

SCHEMBL20558552

CSc1ccccc1.N=C=O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.44
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HSD17B10 Q99714 2/20 0.40
POLB P06746 2/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 2/20 0.39
MGLL Q99685 1/20 0.39
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
AKR1C1 Q04828 1/20 0.39
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylphenylsulfide SCHEMBL28522981 1.00 PTGS2 (0.44) PTGS2KMT2AMEN1MAPTSMN1; SMN2
Methylphenylsulfide SCHEMBL6153558 0.85 KMT2A (0.39) PTGS2KMT2AMEN1MAPTSMN1; SMN2
Methylphenylsulfide SCHEMBL27970000 0.84 MAPT (0.53) PTGS2KMT2AMEN1MAPTSMN1; SMN2
Methylphenylsulfide SCHEMBL27951695 0.84 MAPT (0.53) PTGS2KMT2AMEN1MAPTSMN1; SMN2
Methylphenylsulfide SCHEMBL7584 0.84
Methylphenylsulfide SCHEMBL4902407 0.84
Methylphenylsulfide SCHEMBL1332325 0.84
Methylphenylsulfide SCHEMBL1335985 0.81 MAPT (0.50) PTGS2KMT2AMEN1MAPTSMN1; SMN2
Methylphenylsulfide SCHEMBL6233931 0.81
Methylphenylsulfide SCHEMBL4382713 0.81 MAPT (0.50) PTGS2KMT2AMEN1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3403651-B1 ISOCORYDINE DERIVATIVES, PREPARATION METHOD AND USE THEREOF LANZHOU INST CHEMICAL PHYSICS CAS (CN) 2019-10-30 EP claimed
US-20180334448-A1 Isocorydine derivatives, preparation method and use thereof LANZHOU INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) 2018-11-22 US claimed
EP-3403651-A1 ISOCORYDINE DERIVATIVES, PREPARATION METHOD AND USE THEREOF Lanzhou Institute Of Chemical Physics Chinese Academy of Sciences (CN) 2018-11-21 EP claimed
CN-114380874-B Macrolide antibiotics, preparation method and application thereof 中国医学科学院医药生物技术研究所 2024-06-21 CN disclosed
CN-107488146-B Isocorydine derivative and preparation method and application thereof 中国科学院兰州化学物理研究所 2020-05-22 CN disclosed
EP-3403651-B1 ISOCORYDINE DERIVATIVES, PREPARATION METHOD AND USE THEREOF LANZHOU INST CHEMICAL PHYSICS CAS (CN) 2019-10-30 EP disclosed
US-20180334448-A1 Isocorydine derivatives, preparation method and use thereof LANZHOU INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) 2018-11-22 US disclosed
EP-3403651-A1 ISOCORYDINE DERIVATIVES, PREPARATION METHOD AND USE THEREOF Lanzhou Institute Of Chemical Physics Chinese Academy of Sciences (CN) 2018-11-21 EP disclosed
CN-108475514-A Kit containing sealant and photopolymer 科思创德国股份有限公司 2018-08-31 CN disclosed
CN-107922360-A Substituted triazines and process for their preparation 科思创德国股份有限公司 2018-04-17 CN disclosed
CN-107438515-A Method for producing an optical cast with a holographic optical element and optical cast 科思创德国股份有限公司 2017-12-05 CN disclosed
CN-107223121-A Wet stable holographic media 科思创德国股份有限公司 2017-09-29 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180334448-A1 Isocorydine derivatives, preparation method and use thereof CCND2, CCND3, IDH3A PTGS2 477/4885KMT2A 2096/4885MEN1 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.